VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400
- 24 February 2008
- journal article
- letter
- Published by Springer Nature in Nature Cell Biology
- Vol. 10 (3) , 361-369
- https://doi.org/10.1038/ncb1699
Abstract
Germline von Hippel–Lindau tumour suppressor gene (VHL) mutations cause renal cell carcinomas, haemangioblastomas and phaeochromocytomas in humans1. Mutations in VHL also occur in sporadic renal cell carcinomas. The protein encoded by VHL, VHL, is part of the ubiquitin ligase that downregulates the heterodimeric transcription factor Hif under well-oxygenated conditions1. Here we show that acute VHL inactivation causes a senescent-like phenotype in vitro and in vivo. This phenotype was independent of p53 and Hif but dependent on the retinoblastoma protein (Rb) and the SWI2/SNF2 chromatin remodeller p400. Rb activation occurred through a decrease in Skp2 messenger RNA, which resulted in the upregulation of p27 in a Hif-independent fashion. Our results suggest that senescence induced by VHL inactivation is a tumour-suppressive mechanism that must be overcome to develop VHL-associated neoplasias.Keywords
This publication has 33 references indexed in Scilit:
- von Hippel-Lindau DiseaseAnnual Review Of Pathology-Mechanisms Of Disease, 2007
- The thorny path linking cellular senescence to organismal agingMechanisms of Ageing and Development, 2005
- Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesisNature, 2005
- BRAFE600-associated senescence-like cell cycle arrest of human naeviNature, 2005
- Senescence in premalignant tumoursNature, 2005
- Intrinsic tumour suppressionNature, 2004
- Vascular tumors in livers with targeted inactivation of the von Hippel–Lindau tumor suppressorProceedings of the National Academy of Sciences, 2001
- Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4aCell, 1997
- DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts.Genes & Development, 1994
- SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility geneCell, 1988